SGP compared with PBLS: revenue, margins and what each company keeps, and the suppliers and customers both name

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

PBLSParabilis Medicines, Inc.

Mkt capRevenueRevenue

Compare

SGPSpyGlass Pharma, Inc.

PBLSParabilis Medicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SGPSpyGlass Pharma, Inc.

34.62▲+2.91%· post 34.62

Mkt cap$1.1BRevenue—

PBLSParabilis Medicines, Inc.

27.29▲+0.15%· post 29.29

ClosedNov 3 '26

Mkt cap$787.8MRevenue$148,000Q2 FY26

Compare

ClosedNov 3 '26

SGPSpyGlass Pharma, Inc.

PBLSParabilis Medicines, Inc.

34.62▲+2.91%post 34.62

Price

27.29▲+0.15%post 29.29

$1.1B

Mkt cap

$787.8M

—

Revenue

$148,000Q2 FY26

SGP34.62▲+2.91%vsPBLS27.29▲+0.15%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SGP: latest quarter not drawable. PBLS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SGP 1

—Regents of the University of Colorado (CU)unlistedsupplier

Shared 0

No shared counterparties.

Only PBLS 2

REGNRegeneron Pharmaceuticalscustomer

—Alcamiunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

SGP, solidPBLS, dashed